(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Evaluation summary: visual inspections were performed on the returned device.The deployment difficulty was unable to be confirmed as the stent had already been deployed.The tip detachment was confirmed.The tip detachment likely occurred due to pulling the partially deployed stent through the restricted area of the introducer sheath exceeds the tensile strength of the tip lumen.The investigation was unable to determine a conclusive cause for the reported deployment issue.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other incidents.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that the procedure was to treat a chronic totally occluded, moderately tortuous, and mildly calcified lesion in the proximal femoral artery.Following pre-dilatation with an armada 35 balloon catheter at 20 atmospheres, a 5.5x150mm supera self-expanding stent system (sess) was advanced; however, could not fully deploy even though the deployment lock was unlocked and the thumb slide was advanced to the most distal position on the handle.A larger sheath was advanced to successfully retrieve the stent from the patient anatomy.The delivery system was removed under fluoroscopy.The procedure was successfully completed with a new 5.5x150mm supera sess.There were no adverse patient effects and no clinically significant delay in the procedure.Additional information was received: the return device analysis found that the tip jacket and inner member were separated at the distal end of the ratchet stem.Follow-up with the account indicated that this occurred when an attempt to release the delivery system was made.No additional information was provided.
|